General

On 1 May 2021 Epidyolex, the first medicinal cannabis drug product was listed on the Pharmaceutical Benefits Scheme (PBS). The costs of drug products listed on the PBS are subsidised by the Australian Government. Epidyolex is used in combination with at least two other anti-epileptic medicines to treat Dravet syndrome – a genetic epileptic disease that gives rise to seizures that doesn’t respond well to standard medications. While Epidyolex is the second medicinal cannabis drug registered for...